South Asian garment makers anxious about future after Trump's ‘shock' tariffs: 'Terrible for business'
Manufacturers and suppliers across Asia are anxious over the future of apparel hubs following Donald Trump's sweeping tariffs that they believe could endanger their businesses.
The US president on Wednesday slapped particularly harsh tariffs on major apparel manufacturing countries in Asia, with Cambodia being hit by 49 per cent levies, followed by Vietnam with 46 per cent, Bangladesh with 37 per cent, Indonesia with 32 per cent and "very good friend" India at 26 per cent.
The tariffs have pushed companies in mostly impoverished South Asian countries such as Sri Lanka and Bangladesh – both nations that have recently witnessed political upheaval and a socio-economic crisis – to press government officials to negotiate with the Trump administration to prevent foreign buyers bolting to save costs.
The tariff hike will directly impact the fast-fashion retailers and sportswear brands manufactured in Vietnam, Bangladesh, Indonesia and Sri Lanka.
The US is one of the world's largest consumers of apparel and footwear, but only 2.5 per cent of the US apparel market and 1 per cent of footwear are produced domestically.
Manufacturing hubs in South Asia got a boost during President Trump's first term, when tariffs on China pushed apparel and footwear makers to shift to other parts of Asia. However, the hefty tariffs have left them nowhere to hide.
"We knew something was coming, but we never expected it to be this drastic ... This is terrible for our business and for thousands of workers," garment exporter Shahidullah Azim, whose clients include North American and European retailers, told Reuters.
Mr Azim said his company, which employs 3,200 factory workers, was bracing for order cancellations as rising costs for buyers could spell the end of Bangladesh's competitive edge.
The ready-made garment industry is of existential importance to Bangladesh's economy, accounting for more than 80 per cent of total export earnings, employing 4 million people, mostly women, and contributing roughly 10 per cent to its annual GDP.
Bangladesh, the second-largest producer after China, produces garments for global brands such as Carrefour, Tire, Uniqlo, Primark, H&M and Zara. Manufacturers rued that buyers would be forced to choose other cost-competitive markets, which would be a massive blow to the industry in Bangladesh.
The International Apparel Federation, which represents garment manufacturers in 40 countries, called the tariffs a "major shock", adding: "Ultimately, someone will have to pay the price."
In Sri Lanka, the garment industry exports about 40 per cent of its output to the US, which helped the island nation earn $1.9bn last year, following a massive economic crisis that triggered a mass protest against the government in 2022
The tariffs will hurt more than 350,000 employees of the garment industry. Apparel is also Sri Lanka's second largest foreign exchange earner, which helped the country limp back to economic stability following the protests.
Sri Lankan president Anura Kumara Dissanayake's office said in a statement that a panel of government officials and apparel companies has been formed to study "potential issues" that could arise from the new tariffs.
"Sri Lanka could very quickly see its share of US business move to countries with lower tariffs," said Yohan Lawrence, Secretary General of Sri Lanka's Joint Apparel Association Forum. "This situation is serious, and it must be addressed as a matter of national urgency."
Trade group United States Fashion Industry Association said they were "deeply disappointed by the Trump Administration's decision to impose new tariffs on all imports". It added that the action will "particularly affect American fashion brands and retailers'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
35 minutes ago
- The Independent
Zelenskyy warns oil price surge could help Russia's war effort
A sharp rise in global oil prices following Israeli strikes on Iran will benefit Russia and bolster its military capabilities in the war in Ukraine, Ukrainian President Volodymyr Zelenskyy said Friday in comments that were under embargo until Saturday afternoon. Speaking to journalists in Kyiv, Zelenskyy said the surge in oil prices threatens Ukraine's position on the battlefield, especially because Western allies have not enforced effective price caps on Russian oil exports. 'The strikes led to a sharp increase in the price of oil, which is negative for us,' Zelenskyy said. 'The Russians are getting stronger due to greater income from oil exports.' Global oil prices rose as much as 7% after Israel and Iran exchanged attacks over the past 48 hours, raising concerns that further escalation in the region could disrupt oil exports from the Middle East. Zelenskyy to address concerns with the US Zelenskyy said he planned to raise the issue in an upcoming conversation with U.S. President Donald Trump. 'In the near future, I will be in contact with the American side, I think with the president, and we will raise this issue,' he said. Zelenskyy also expressed concern that U.S. military aid could be diverted away from Ukraine toward Israel during renewed tensions in the Middle East. 'We would like aid to Ukraine not to decrease because of this,' he said. 'Last time, this was a factor that slowed down aid to Ukraine.' Ukraine's military needs have been sidelined by the United States in favor of supporting Israel, Zelenskyy said, citing a shipment of 20,000 interceptor missiles, designed to counter Iran-made Shahed drones, that had been intended for Ukraine but were redirected to Israel. 'And for us it was a blow,' he said. 'When you face 300 to 400 drones a day, most are shot down or go off course, but some get through. We were counting on those missiles.' An air defense system, Barak-8, promised to Ukraine by Israeli President Benjamin Netanyahu was sent to the U.S. for repairs but never delivered to Ukraine, Zelenskyy said. The Ukrainian president conceded that momentum for the Coalition of the Willing, a group of 31 countries which have pledged to strengthen support for Ukraine against Russian aggression, has slowed because of U.S. ambivalence over providing a backstop. 'This situation has shown that Europe has not yet decided for itself that it will be with Ukraine completely if America is not there,' he said. Coalition of the Willing offer under consideration The offer of a foreign troop 'reassurance force' pledged by the Coalition of the Willing was still on the table 'but they need a backstop, as they say, from America,' Zelenskyy said. 'This means that suddenly, if something happens, America will be with them and with Ukraine.' The Ukrainian president also said the presence of foreign contingents in Ukraine would act as a security guarantee and allow Kyiv to make territorial compromises, which is the first time he has articulated a link between the reassurance force and concessions Kyiv is willing to make in negotiations with Russia. 'It is simply that their presence gives us the opportunity to compromise, when we can say that today our state does not have the strength to take our territories within the borders of 1991,' he said. But Europe and Ukraine are still waiting on strong signals from Trump. Without crushing U.S. sanctions against Russia, 'I will tell you frankly, it will be very difficult for us,' Zelenskyy said, adding that it would then fall on Europe to step up military aid to Ukraine. Body and prisoner returns follow Istanbul talks In other developments, Russia repatriated more bodies of fallen soldiers in line with an agreement reached during peace talks in Istanbul between Russian and Ukrainian delegations, Russian officials said Saturday, cited by Russian state media. The officials said Ukraine did not return any bodies to Russia on Saturday. Ukraine's Coordination Headquarters for the Treatment of Prisoners of War confirmed in a statement that Russia returned 1,200 bodies. The first round of the staggered exchanges took place Monday. The agreement to exchange prisoners of war and the bodies of fallen soldiers was the only tangible outcome of the talks in Istanbul on June 2. Russia says push continues Continuing a renewed battlefield push along eastern and northeastern parts of the more than 1,000-kilometer (over 600-mile) front line, the Russian Defense Ministry claimed Saturday that its troops captured another village in the Donetsk region, Zelenyi Kut. The Ukrainian military had no immediate comment on the Russian claim. Russia launched 58 drones and decoys at Ukraine overnight into Saturday, according to the Ukrainian air force, which said its air defenses destroyed 23 drones while another 20 were jammed. Russia's defense ministry said it shot down 66 Ukrainian drones overnight. Attacks have continued despite discussions of a potential ceasefire in the war. During the June 2 talks in Istanbul, Russian and Ukrainian negotiators traded memorandums containing sharply divergent conditions that both sides see as nonstarters, making a quick deal unlikely. ___
The Independent
an hour ago
- The Independent
What's left for the Supreme Court to decide? 21 cases, including state bans on transgender care
The Supreme Court is in the homestretch of a term that has lately been dominated by the Trump administration's emergency appeals of lower court orders seeking to slow President Donald Trump 's efforts to remake the federal government. But the justices also have 21 cases to resolve that were argued between December and mid-May, including a push by Republican-led states to ban gender-affirming care for transgender minors. One of the argued cases was an emergency appeal, the administration's bid to be allowed to enforce Trump's executive order denying birthright citizenship to U.S.-born children of parents who are in the country illegally. The court typically aims to finish its work by the end of June. Here are some of the biggest remaining cases: The oldest unresolved case, and arguably the term's biggest, stems from a challenge to Tennessee's law from transgender minors and their parents who argue that it is unconstitutional sex discrimination aimed at a vulnerable population. At arguments in December, the court's conservative majority seemed inclined to uphold the law, voicing skepticism of claims that it violates the 14th amendment's equal protection clause. The post-Civil War provision requires the government to treat similarly situated people the same. The court is weighing the case amid a range of other federal and state efforts to regulate the lives of transgender people, including which sports competitions they can join and which bathrooms they can use. In April, Trump's administration sued Maine for not complying with the government's push to ban transgender athletes in girls sports. Trump also has sought to block federal spending on gender-affirming care for those under 19 and a conservative majority of justices allowed him to move forward with plans to oust transgender people from the U.S. military. Trump's birthright citizenship order has been blocked by lower courts The court rarely hears arguments over emergency appeals, but it took up the administration's plea to narrow orders that have prevented the citizenship changes from taking effect anywhere in the U.S. The issue before the justices is whether to limit the authority of judges to issue nationwide injunctions, which have plagued both Republican and Democratic administrations in the past 10 years. These nationwide court orders have emerged as an important check on Trump's efforts and a source of mounting frustration to the Republican president and his allies. At arguments last month, the court seemed intent on keeping a block on the citizenship restrictions while still looking for a way to scale back nationwide court orders. It was not clear what such a decision might look like, but a majority of the court expressed concerns about what would happen if the administration were allowed, even temporarily, to deny citizenship to children born to parents who are in the country illegally. Democratic-led states, immigrants and rights groups who sued over Trump's executive order argued that it would upset the settled understanding of birthright citizenship that has existed for more than 125 years. The court seems likely to side with Maryland parents in a religious rights case over LGBTQ storybooks in public schools Parents in the Montgomery County school system, in suburban Washington, want to be able to pull their children out of lessons that use the storybooks, which the county added to the curriculum to better reflect the district's diversity. The school system at one point allowed parents to remove their children from those lessons, but then reversed course because it found the opt-out policy to be disruptive. Sex education is the only area of instruction with an opt-out provision in the county's schools. The school district introduced the storybooks in 2022, with such titles as 'Prince and Knight' and 'Uncle Bobby's Wedding.' The case is one of several religious rights cases at the court this term. The justices have repeatedly endorsed claims of religious discrimination in recent years. The decision also comes amid increases in recent years in books being banned from public school and public libraries. A three-year battle over congressional districts in Louisiana is making its second trip to the Supreme Court Lower courts have struck down two Louisiana congressional maps since 2022 and the justices are weighing whether to send state lawmakers back to the map-drawing board for a third time. The case involves the interplay between race and politics in drawing political boundaries in front of a conservative-led court that has been skeptical of considerations of race in public life. At arguments in March, several of the court's conservative justices suggested they could vote to throw out the map and make it harder, if not impossible, to bring redistricting lawsuits under the Voting Rights Act. Before the court now is a map that created a second Black majority congressional district among Louisiana's six seats in the House of Representatives. The district elected a Black Democrat in 2024. A three-judge court found that the state relied too heavily on race in drawing the district, rejecting Louisiana's arguments that politics predominated, specifically the preservation of the seats of influential members of Congress, including Speaker Mike Johnson. The Supreme Court ordered the challenged map to be used last year while the case went on. Lawmakers only drew that map after civil rights advocates won a court ruling that a map with one Black majority district likely violated the landmark voting rights law. The justices are weighing a Texas law aimed at blocking kids from seeing online pornography Texas is among more than a dozen states with age verification laws. The states argue the laws are necessary as smartphones have made access to online porn, including hardcore obscene material, almost instantaneous. The question for the court is whether the measure infringes on the constitutional rights of adults as well. The Free Speech Coalition, an adult-entertainment industry trade group, agrees that children shouldn't be seeing pornography. But it says the Texas law is written too broadly and wrongly affects adults by requiring them to submit personal identifying information online that is vulnerable to hacking or tracking. The justices appeared open to upholding the law, though they also could return it to a lower court for additional work. Some justices worried the lower court hadn't applied a strict enough legal standard in determining whether the Texas law and others like that could run afoul of the First Amendment.
The Independent
an hour ago
- The Independent
The cost of staying alive could become a lot more expensive for millions of Americans because of Trump drug tariffs
Americans would likely pay more for necessary everyday prescription drugs, such as insulin, painkillers, chemotherapy, or antibiotics, if President Donald Trump were to enact tariffs on pharmaceuticals, experts warn. In an effort to incentivize drug manufacturers to bring production back to the United States, Trump has proposed tariffing pharmaceuticals made overseas – which account for an overwhelming majority of everyday medicine used in the U.S. 'We're going to be doing that,' Trump said of pharmaceutical tariffs in April. 'That's going to be like we have on cars. You know we have a 25 percent tariff on cars, we have a 25 percent tariff on steel and aluminum, and that's what the [pharmaceutical] category fits right now.' 'The higher the tariff, the faster they come,' Trump said. But experts say that's not necessarily true and there would be tangible consequences to such action, from higher brand-name drug prices to generic drug shortages. 'If tariffs were applied to prescription drugs, one of the most immediate consequences could be price increases — on prices that we already pay way in excess of other countries,' Dr. Mariana Socal, an associate professor at the Johns Hopkins Bloomberg School of Public Health, said. The U.S. imports a majority of its branded prescription drugs – or medications that are patented with a brand name such as Viagra, Wegovy, or Zoloft – from high-income countries. Dr. Jeromie Ballreich, an associated research professor at Johns Hopkins Bloomberg School of Public Health, said much of the manufacturing comes from Ireland, Germany, and Switzerland because they have favorable tax policies for companies. As a result, adding a tariff would only make it more expensive for pharmacies and insurance companies to keep them in supply. 'We would expect pharma to pass the costs onto the insurers and we would expect insurers to pass the cost onto the individual patients,' Ballreich said. 'So, if there is a 50 percent tariff on your insulin product because it's coming from Ireland, patients in Mississippi who get insulin – they will either be faced with a higher cost when they go up to the pharmacy to fill their insulin or they're going to face a higher indirect cost because the premiums of the insurance plan are going to go up,' he said. Ballreich said a tariff on countries that produce high quantities of branded drugs would put 'pressure' on public insurers like Medicare or Medicaid and private insurers. However, branded drugs only account for roughly 10 to 15 percent of prescriptions. A majority of Americans, up to 90 percent, use generic drugs, often manufactured in India and China, because they're cheaper. Making branded drugs less accessible through tariffs would only increase reliance on generic drugs, which could exacerbate shortages that already impact millions of Americans. Generic drugs would become less available '[Shortages] can have very significant implications in day-to-day clinical practice,' Socal said. 'For example, if you are administering chemotherapy for an oncology patient, that may have significant consequences even for the prognosis of that case moving forward.' In 2024, the U.S. experienced a shortage of more than 300 drugs – 70 percent of which were generic prescriptions. Socal said that when patients are not able to access a more affordable version of their prescription, it means they may put their health at risk by skipping a dosage, taking a lower dosage, or not filling their prescription at all. Otherwise, they're forced to turn to the more expensive branded version. 'Those more expensive drugs are not always the best,' Socal said. 'Very frequently, and we saw this with chemotherapy shortages, the available drugs are second-line drugs.' Tariffs won't necessarily increase domestic manufacturing The president has indicated that any negative impact from tariffs may be temporary and worth it to bring manufacturing and jobs back. 'We're doing it because we want to make our own drugs,' Trump said. But Ballreich and Socal are more skeptical. 'Tariffs are a very blunt instrument to incentivize domestic U.S. manufacturing of the branded drugs we use,' Ballreich said. Given pharmaceutical companies have moved outside of the U.S. for tax purposes, Ballreich says tax policy may be a better way to incentivize them, especially since many of those drugs are more difficult to manufacture. 'It's not just a very simple chemical plant; these tend to be very complex,' he said. Socal suggested a better strategy would be to understand where drugs are being manufactured and which ones would make more sense to bring to the U.S. — since even those manufactured locally often rely on certain imported ingredients and materials. 'Having tariffs on pharmaceutical products coming from abroad can actually also hurt our domestic manufacturers,' he says. While the president has not officially implemented any tariff policy on pharmaceuticals yet, he said, in April, that the plan would take effect in the 'not too distant future.'
